Antidepressant-like Effects of Combined Fluoxetine and Zinc Treatment in Mice Exposed to Chronic Restraint Stress Are Related to Modulation of Histone Deacetylase

Chronic stress is the key factor contributing to the development of depressive symptoms. Chronic restraint stress (CRS) is well validated and is one of the most commonly used models to induce depressive-like behavior in rodents. The present study aimed to evaluate whether fluoxetine (FLU 5 mg/kg) an...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Molecules (Basel, Switzerland) Ročník 27; číslo 1; s. 22
Hlavní autoři:	Misztak, Paulina, Sowa-Kućma, Magdalena, Pańczyszyn-Trzewik, Patrycja, Szewczyk, Bernadeta, Nowak, Gabriel
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 21.12.2021 MDPI
Témata:	an animal model of depression Animals Antidepressants Antidepressive Agents - pharmacology Anxiety Behavior Behavior, Animal - drug effects Brain chronic restraint stress Cytokines Depression - drug therapy Disease Models, Animal Dose-Response Relationship, Drug Epigenetics fluoxetine Fluoxetine - pharmacology Hindlimb Suspension Histone Deacetylases - metabolism Humans Male Mental depression Mental disorders Mice Mice, Inbred C57BL Oxidative stress Pyroptosis Stress, Psychological - metabolism zinc Zinc - pharmacology antidepressants chronic restraint stress fluoxetine an animal model of depression zinc
ISSN:	1420-3049, 1420-3049
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Chronic stress is the key factor contributing to the development of depressive symptoms. Chronic restraint stress (CRS) is well validated and is one of the most commonly used models to induce depressive-like behavior in rodents. The present study aimed to evaluate whether fluoxetine (FLU 5 mg/kg) and zinc (Zn 10mg/kg) given simultaneously induce a more pronounced antidepressant-like effect in the CRS model than both those compounds given alone. Behavioral assessment was performed using the tail suspension and splash tests (TST and ST, respectively). Furthermore, the effects of CRS, FLU and Zn given alone and combined treatment with FLU + Zn on the expression of proteins involved in the apoptotic, inflammatory, and epigenetic processes were evaluated in selected brain structures (prefrontal cortex, PFC; and hippocampus, Hp) using Western blot analysis or enzyme-linked immunosorbent assays (ELISA). The results obtained indicated that three hours (per day) of immobilization for 4 weeks induced prominent depressive symptoms that manifested as increased immobility time in the TST, as well as decreased number and grooming time in the ST. Behavioral changes induced by CRS were reversed by both FLU (5 and 10 mg/kg) or Zn (10 mg/kg). Zinc supplementation (10 mg/kg) slightly increases the effectiveness of FLU (5 mg/kg) in the TST. However, it significantly increased the activity of FLU in the ST compared to the effect induced by FLU and Zn alone. Biochemical studies revealed that neither CRS nor FLU and Zn given alone or in combined treatment alter the expression of proteins involved in apoptotic or inflammatory processes. CRS induced major alterations in histone deacetylase (HDAC) levels by increasing the level of HADC1 and decreasing the level of HADC4 in the PFC and Hp, decreasing the level of HADC6 in the PFC but increasing it in Hp. Interestingly, FLU + Zn treatment reversed CRS-induced changes in HDAC levels in the Hp, indicating that HDAC modulation is linked to FLU + Zn treatment and this effect is structure-specific.
AbstractList	Chronic stress is the key factor contributing to the development of depressive symptoms. Chronic restraint stress (CRS) is well validated and is one of the most commonly used models to induce depressive-like behavior in rodents. The present study aimed to evaluate whether fluoxetine (FLU 5 mg/kg) and zinc (Zn 10mg/kg) given simultaneously induce a more pronounced antidepressant-like effect in the CRS model than both those compounds given alone. Behavioral assessment was performed using the tail suspension and splash tests (TST and ST, respectively). Furthermore, the effects of CRS, FLU and Zn given alone and combined treatment with FLU + Zn on the expression of proteins involved in the apoptotic, inflammatory, and epigenetic processes were evaluated in selected brain structures (prefrontal cortex, PFC; and hippocampus, Hp) using Western blot analysis or enzyme-linked immunosorbent assays (ELISA). The results obtained indicated that three hours (per day) of immobilization for 4 weeks induced prominent depressive symptoms that manifested as increased immobility time in the TST, as well as decreased number and grooming time in the ST. Behavioral changes induced by CRS were reversed by both FLU (5 and 10 mg/kg) or Zn (10 mg/kg). Zinc supplementation (10 mg/kg) slightly increases the effectiveness of FLU (5 mg/kg) in the TST. However, it significantly increased the activity of FLU in the ST compared to the effect induced by FLU and Zn alone. Biochemical studies revealed that neither CRS nor FLU and Zn given alone or in combined treatment alter the expression of proteins involved in apoptotic or inflammatory processes. CRS induced major alterations in histone deacetylase (HDAC) levels by increasing the level of HADC1 and decreasing the level of HADC4 in the PFC and Hp, decreasing the level of HADC6 in the PFC but increasing it in Hp. Interestingly, FLU + Zn treatment reversed CRS-induced changes in HDAC levels in the Hp, indicating that HDAC modulation is linked to FLU + Zn treatment and this effect is structure-specific.Chronic stress is the key factor contributing to the development of depressive symptoms. Chronic restraint stress (CRS) is well validated and is one of the most commonly used models to induce depressive-like behavior in rodents. The present study aimed to evaluate whether fluoxetine (FLU 5 mg/kg) and zinc (Zn 10mg/kg) given simultaneously induce a more pronounced antidepressant-like effect in the CRS model than both those compounds given alone. Behavioral assessment was performed using the tail suspension and splash tests (TST and ST, respectively). Furthermore, the effects of CRS, FLU and Zn given alone and combined treatment with FLU + Zn on the expression of proteins involved in the apoptotic, inflammatory, and epigenetic processes were evaluated in selected brain structures (prefrontal cortex, PFC; and hippocampus, Hp) using Western blot analysis or enzyme-linked immunosorbent assays (ELISA). The results obtained indicated that three hours (per day) of immobilization for 4 weeks induced prominent depressive symptoms that manifested as increased immobility time in the TST, as well as decreased number and grooming time in the ST. Behavioral changes induced by CRS were reversed by both FLU (5 and 10 mg/kg) or Zn (10 mg/kg). Zinc supplementation (10 mg/kg) slightly increases the effectiveness of FLU (5 mg/kg) in the TST. However, it significantly increased the activity of FLU in the ST compared to the effect induced by FLU and Zn alone. Biochemical studies revealed that neither CRS nor FLU and Zn given alone or in combined treatment alter the expression of proteins involved in apoptotic or inflammatory processes. CRS induced major alterations in histone deacetylase (HDAC) levels by increasing the level of HADC1 and decreasing the level of HADC4 in the PFC and Hp, decreasing the level of HADC6 in the PFC but increasing it in Hp. Interestingly, FLU + Zn treatment reversed CRS-induced changes in HDAC levels in the Hp, indicating that HDAC modulation is linked to FLU + Zn treatment and this effect is structure-specific. Chronic stress is the key factor contributing to the development of depressive symptoms. Chronic restraint stress (CRS) is well validated and is one of the most commonly used models to induce depressive-like behavior in rodents. The present study aimed to evaluate whether fluoxetine (FLU 5 mg/kg) and zinc (Zn 10mg/kg) given simultaneously induce a more pronounced antidepressant-like effect in the CRS model than both those compounds given alone. Behavioral assessment was performed using the tail suspension and splash tests (TST and ST, respectively). Furthermore, the effects of CRS, FLU and Zn given alone and combined treatment with FLU + Zn on the expression of proteins involved in the apoptotic, inflammatory, and epigenetic processes were evaluated in selected brain structures (prefrontal cortex, PFC; and hippocampus, Hp) using Western blot analysis or enzyme-linked immunosorbent assays (ELISA). The results obtained indicated that three hours (per day) of immobilization for 4 weeks induced prominent depressive symptoms that manifested as increased immobility time in the TST, as well as decreased number and grooming time in the ST. Behavioral changes induced by CRS were reversed by both FLU (5 and 10 mg/kg) or Zn (10 mg/kg). Zinc supplementation (10 mg/kg) slightly increases the effectiveness of FLU (5 mg/kg) in the TST. However, it significantly increased the activity of FLU in the ST compared to the effect induced by FLU and Zn alone. Biochemical studies revealed that neither CRS nor FLU and Zn given alone or in combined treatment alter the expression of proteins involved in apoptotic or inflammatory processes. CRS induced major alterations in histone deacetylase (HDAC) levels by increasing the level of HADC1 and decreasing the level of HADC4 in the PFC and Hp, decreasing the level of HADC6 in the PFC but increasing it in Hp. Interestingly, FLU + Zn treatment reversed CRS-induced changes in HDAC levels in the Hp, indicating that HDAC modulation is linked to FLU + Zn treatment and this effect is structure-specific.
Author	Szewczyk, Bernadeta Misztak, Paulina Sowa-Kućma, Magdalena Nowak, Gabriel Pańczyszyn-Trzewik, Patrycja
AuthorAffiliation	3 Department of Human Physiology, Institute of Medical Sciences, Medical College of Rzeszow University, Kopisto 2a, 35-959 Rzeszow, Poland; msowa@ur.edu.pl (M.S.-K.); ppanczyszyn@ur.edu.pl (P.P.-T.) 1 Department of Pharmacobiology, Jagiellonian University Medical College, Medyczna 9, 30-668 Krakow, Poland; nowak@if-pan.krakow.pl (G.N.) 2 Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland
AuthorAffiliation_xml	– name: 3 Department of Human Physiology, Institute of Medical Sciences, Medical College of Rzeszow University, Kopisto 2a, 35-959 Rzeszow, Poland; msowa@ur.edu.pl (M.S.-K.); ppanczyszyn@ur.edu.pl (P.P.-T.) – name: 1 Department of Pharmacobiology, Jagiellonian University Medical College, Medyczna 9, 30-668 Krakow, Poland; nowak@if-pan.krakow.pl (G.N.) – name: 2 Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343 Krakow, Poland
Author_xml	– sequence: 1 givenname: Paulina surname: Misztak fullname: Misztak, Paulina – sequence: 2 givenname: Magdalena orcidid: 0000-0001-5956-7229 surname: Sowa-Kućma fullname: Sowa-Kućma, Magdalena – sequence: 3 givenname: Patrycja orcidid: 0000-0001-8760-7494 surname: Pańczyszyn-Trzewik fullname: Pańczyszyn-Trzewik, Patrycja – sequence: 4 givenname: Bernadeta orcidid: 0000-0002-6863-7951 surname: Szewczyk fullname: Szewczyk, Bernadeta – sequence: 5 givenname: Gabriel orcidid: 0000-0002-3000-7938 surname: Nowak fullname: Nowak, Gabriel
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/35011254$$D View this record in MEDLINE/PubMed
BookMark	eNp9kktvFDEMx0eoiD7gA3BBkbhwWUgmyTwuSKulL6kVEpQLlyiT8bRZMsk2yaD26_BJ690tVVskDlFs5-d_Etv7xY4PHoriLaMfOW_ppzE4MJODVNaUUVqWL4o9Jko641S0O4_s3WI_pSUSTDD5qtjlkjJWSrFX_Jn7bHtYRUhJ-zxz9heQw2EAkxMJA1mEsbMeenLkpnADGW2ifU9-Wm_IRQSdR_CZWE_OrcHMm1VISOdAFlcxeGvIN0g5aovQ97y-hcwjYNDpvOXOQz-hY4Nf33diU8ZPki-gDeRbpxO8Ll4O2iV4c78fFD-ODi8WJ7Ozr8eni_nZzIiW51kjTTU0lagGKmnDy1r0nA591dGqbE3HZYku1_WgW11L3rV9bVhDZdczaIyR_KA43er2QS_VKtpRx1sVtFWbQIiXSsdsjQNF26prcAna1QJAtrSDth6YBiwx1x1qfd5qraZuhN5gjaJ2T0Sfnnh7pS7Db9XUopKMo8CHe4EYricsoRptMuCc9hCmpMqKNS2rse-Ivn-GLsMUPZZqQ5WCSl4h9e7xix6e8ncUEGBbwMSQUoThAWFUrcdN_TNumFM_yzE2b3q5brn7T-YdqPve7w
CitedBy_id	crossref_primary_10_1016_j_ejphar_2024_176757 crossref_primary_10_3390_biomedicines12092116 crossref_primary_10_1016_j_jinorgbio_2025_112857 crossref_primary_10_3389_fncel_2024_1406832 crossref_primary_10_1016_j_bbr_2022_114208 crossref_primary_10_1016_j_neuropharm_2023_109729 crossref_primary_10_3390_ijms24087098 crossref_primary_10_3389_fmolb_2025_1595602 crossref_primary_10_3389_fnins_2023_1289019 crossref_primary_10_1016_j_pharmthera_2022_108279 crossref_primary_10_1111_ejn_16455
Cites_doi	10.1016/j.neuropharm.2017.01.033 10.1016/j.biopsych.2009.09.033 10.1016/S1734-1140(11)70520-5 10.1016/j.tips.2010.12.002 10.1016/j.biopsych.2011.07.017 10.1016/j.neuropharm.2011.08.045 10.1016/j.jpsychires.2009.08.015 10.1016/S1734-1140(13)71517-2 10.1016/j.neuropharm.2015.08.026 10.1038/tp.2014.125 10.1037/a0035302 10.1016/j.bbr.2018.02.009 10.1016/j.ajp.2017.01.025 10.3390/ijms22041840 10.1016/j.neulet.2010.07.084 10.1016/j.jad.2019.02.041 10.1371/journal.pone.0030924 10.1385/NMM:5:1:011 10.12659/MSM.912401 10.5607/en.2019.28.4.537 10.1016/j.pharep.2017.08.001 10.1016/j.tins.2009.06.002 10.1016/j.neuron.2018.08.031 10.1038/srep45907 10.1016/j.brainres.2019.03.020 10.1016/j.neuron.2009.04.017 10.1016/j.repbio.2019.10.003 10.3389/fnmol.2016.00114 10.1038/s41598-020-73298-4 10.1007/s12264-013-1378-z 10.1007/s00213-016-4498-0 10.1016/j.neuropharm.2014.02.017 10.1016/j.bbrc.2017.03.093 10.1016/S0361-9230(03)00104-7 10.1016/j.neuropharm.2014.04.015 10.1007/s12640-017-9835-5 10.1007/s12035-015-9408-7 10.1016/j.phrs.2019.104310 10.3390/diagnostics11010123 10.1016/j.pnpbp.2015.03.010 10.1248/bpb.b17-00131 10.1684/mrh.2018.0442 10.1016/j.ynstr.2020.100286 10.1038/srep35042 10.2147/JIR.S141033 10.1016/j.pnpbp.2010.02.010 10.1007/s11064-016-2110-y 10.1016/j.jad.2016.03.017 10.1016/j.euroneuro.2015.08.016 10.1177/2470547016687996 10.1007/s00702-019-02084-y 10.1016/j.pharep.2015.01.015 10.1007/s00213-014-3671-6 10.1038/srep08415 10.1002/prp2.472 10.1016/j.pnpbp.2010.08.026 10.1080/15592294.2016.1146850 10.3390/nu12092529 10.1016/j.pnpbp.2007.03.004 10.1016/j.neuroscience.2004.06.054 10.1523/JNEUROSCI.1758-09.2009 10.3389/fnagi.2013.00033 10.1007/s10571-016-0344-5 10.1016/j.bbr.2017.04.020 10.1016/j.brainresbull.2018.10.010 10.3389/fnmol.2017.00248 10.1590/S0100-879X2000000100011 10.3389/fphar.2020.00537 10.1016/j.bbr.2007.11.012 10.4110/in.2016.16.4.242 10.1089/ars.2012.4720 10.1038/srep08171 10.1016/j.pnpbp.2006.12.014 10.1016/j.bbr.2016.11.044 10.1016/j.neuroscience.2010.01.062 10.1371/journal.pone.0179399 10.1016/j.neuropharm.2004.07.035 10.1016/j.pnpbp.2017.08.024 10.1038/nrc883 10.1016/j.bbadis.2017.11.012 10.1016/j.bbi.2012.12.008 10.1016/j.ejphar.2004.03.038 10.20463/jenb.2016.09.20.3.3 10.1016/j.bbr.2010.08.044 10.1007/s00702-008-0115-7 10.1016/j.pnpbp.2007.11.012 10.1016/j.jpsychires.2011.01.016
ContentType	Journal Article
Copyright	2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021
Copyright_xml	– notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA
DOI	10.3390/molecules27010022
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic Publicly Available Content Database CrossRef MEDLINE
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Chemistry
EISSN	1420-3049
ExternalDocumentID	oai_doaj_org_article_096b896b40b74ee590be97f1ae0213ab PMC8746513 35011254 10_3390_molecules27010022
Genre	Journal Article
GrantInformation_xml	– fundername: National Science Center grantid: 2016/21/N/NZ4/03252
GroupedDBID	--- 0R~ 123 2WC 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIWK ACPRK ACUHS AEGXH AENEX AFFHD AFKRA AFPKN AFRAH AFZYC AIAGR ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 E3Z EBD EMOBN ESTFP ESX FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE HZ~ I09 IAO IHR ITC KQ8 LK8 M1P MODMG O-U O9- OK1 P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO RPM SV3 TR2 TUS UKHRP ~8M ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c493t-85c6f8646f05083274d30fd6b0629cb35230f3a7fa9a753b9d7c1805bd1e8cc53
IEDL.DBID	DOA
ISICitedReferencesCount	12
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000751068800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1420-3049
IngestDate	Fri Oct 03 12:45:20 EDT 2025 Tue Nov 04 01:52:12 EST 2025 Mon Sep 08 14:13:32 EDT 2025 Tue Oct 07 07:35:12 EDT 2025 Thu Apr 03 07:00:35 EDT 2025 Sat Nov 29 07:17:35 EST 2025 Tue Nov 18 20:44:37 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	antidepressants chronic restraint stress fluoxetine an animal model of depression zinc
Language	English
License	Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c493t-85c6f8646f05083274d30fd6b0629cb35230f3a7fa9a753b9d7c1805bd1e8cc53
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-3000-7938 0000-0001-8760-7494 0000-0002-6863-7951 0000-0001-5956-7229
OpenAccessLink	https://doaj.org/article/096b896b40b74ee590be97f1ae0213ab
PMID	35011254
PQID	2618240536
PQPubID	2032355
ParticipantIDs	doaj_primary_oai_doaj_org_article_096b896b40b74ee590be97f1ae0213ab pubmedcentral_primary_oai_pubmedcentral_nih_gov_8746513 proquest_miscellaneous_2618917701 proquest_journals_2618240536 pubmed_primary_35011254 crossref_primary_10_3390_molecules27010022 crossref_citationtrail_10_3390_molecules27010022
PublicationCentury	2000
PublicationDate	20211221
PublicationDateYYYYMMDD	2021-12-21
PublicationDate_xml	– month: 12 year: 2021 text: 20211221 day: 21
PublicationDecade	2020
PublicationPlace	Switzerland
PublicationPlace_xml	– name: Switzerland – name: Basel
PublicationTitle	Molecules (Basel, Switzerland)
PublicationTitleAlternate	Molecules
PublicationYear	2021
Publisher	MDPI AG MDPI
Publisher_xml	– name: MDPI AG – name: MDPI
References	Varghese (ref_14) 2001; 3 Nowak (ref_51) 2004; 492 Boulle (ref_86) 2014; 4 ref_90 Xiao (ref_45) 2019; 146 Yalcin (ref_88) 2011; 70 Xia (ref_13) 2016; 6 Misztak (ref_27) 2018; 70 ref_55 Leng (ref_66) 2018; 100 Liu (ref_82) 2015; 5 Nowak (ref_34) 2015; 67 Rybkina (ref_58) 2016; 53 Iwata (ref_59) 2013; 31 Kim (ref_4) 2017; 329 Szewczyk (ref_49) 2018; 31 ref_19 Kubera (ref_24) 2011; 35 Yi (ref_47) 2017; 486 Christiansen (ref_23) 2011; 216 Fuchikami (ref_75) 2016; 64 Torbati (ref_64) 2019; 1715 Martin (ref_79) 2017; 8 Wang (ref_83) 2019; 28 Ding (ref_48) 2016; 197 Siwek (ref_8) 2013; 65 Slavich (ref_6) 2014; 140 Padovan (ref_20) 2000; 33 Ishizaki (ref_44) 2011; 2011 Carney (ref_56) 2004; 128 Szewczyk (ref_39) 2013; 5 Torrisi (ref_21) 2021; 14 Seo (ref_63) 2016; 20 Abe (ref_73) 2011; 45 Dean (ref_1) 2017; 27 Hongxia (ref_70) 2019; 249 Zheng (ref_30) 2016; 11 Tan (ref_16) 2017; 40 Jeon (ref_25) 2018; 11 Jesko (ref_84) 2017; 42 Schiavone (ref_61) 2013; 18 Han (ref_76) 2014; 81 Masneuf (ref_41) 2014; 85 Duman (ref_53) 2004; 5 Herve (ref_3) 2017; 10 Sun (ref_12) 2013; 29 Nowak (ref_36) 2003; 61 Szewczyk (ref_52) 2015; 99 Ihne (ref_22) 2012; 62 Cory (ref_62) 2002; 2 Styczen (ref_9) 2018; 33 Dowlati (ref_68) 2010; 67 Schmauss (ref_85) 2015; 5 Zhang (ref_81) 2018; 1864 David (ref_87) 2009; 62 Shen (ref_69) 2019; 25 ref_77 Legutko (ref_37) 2008; 115 Erburu (ref_11) 2015; 25 Chuang (ref_31) 2009; 32 Halliwell (ref_40) 2011; 32 Khodamoradi (ref_60) 2019; 19 Pochwat (ref_91) 2015; 232 Szewczyk (ref_35) 2011; 35 Jangra (ref_18) 2017; 37 Cieslik (ref_54) 2011; 63 Can (ref_89) 2012; 59 Planchez (ref_43) 2019; 126 Kim (ref_7) 2007; 31 Frinchi (ref_17) 2017; 234 Ignacio (ref_29) 2017; 320 Hobara (ref_71) 2010; 44 Iga (ref_72) 2007; 31 Corey (ref_78) 2020; 10 Kv (ref_28) 2018; 344 Franco (ref_50) 2008; 188 Wu (ref_33) 2016; 9 Shukla (ref_32) 2020; 11 Erburu (ref_80) 2017; 117 Styczen (ref_10) 2018; 81 ref_42 Blackburn (ref_2) 2019; 7 Campos (ref_15) 2010; 167 Hodes (ref_46) 2010; 484 Vinet (ref_57) 2004; 47 Covington (ref_74) 2009; 29 Cieslik (ref_38) 2007; 59 Salehpour (ref_26) 2019; 144 ref_5 Lee (ref_65) 2016; 16 Slotwinska (ref_67) 2008; 32
References_xml	– volume: 117 start-page: 195 year: 2017 ident: ref_80 article-title: SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2017.01.033 – volume: 67 start-page: 446 year: 2010 ident: ref_68 article-title: A meta-analysis of cytokines in major depression publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2009.09.033 – volume: 63 start-page: 537 year: 2011 ident: ref_54 article-title: Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment publication-title: Pharmacol. Rep. doi: 10.1016/S1734-1140(11)70520-5 – volume: 32 start-page: 125 year: 2011 ident: ref_40 article-title: Free radicals and antioxidants - Quo vadis? publication-title: Trends. Pharmacol. Sci. doi: 10.1016/j.tips.2010.12.002 – volume: 70 start-page: 946 year: 2011 ident: ref_88 article-title: A time-dependent history of mood disorders in a murine model of neuropathic pain publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2011.07.017 – volume: 62 start-page: 464 year: 2012 ident: ref_22 article-title: Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.08.045 – volume: 44 start-page: 263 year: 2010 ident: ref_71 article-title: Altered gene expression of histone deacetylases in mood disorder patients publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2009.08.015 – volume: 65 start-page: 1558 year: 2013 ident: ref_8 article-title: Oxidative stress markers in affective disorders publication-title: Pharmacol. Rep. doi: 10.1016/S1734-1140(13)71517-2 – volume: 99 start-page: 517 year: 2015 ident: ref_52 article-title: Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2015.08.026 – volume: 4 start-page: e485 year: 2014 ident: ref_86 article-title: Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: Normalization by agomelatine publication-title: Transl. Psychiatry doi: 10.1038/tp.2014.125 – volume: 140 start-page: 774 year: 2014 ident: ref_6 article-title: From stress to inflammation and major depressive disorder: A social signal transduction theory of depression publication-title: Psychol. Bull. doi: 10.1037/a0035302 – volume: 344 start-page: 73 year: 2018 ident: ref_28 article-title: Antidepressant activity of vorinostat is associated with amelioration of oxidative stress and inflammation in a corticosterone-induced chronic stress model in mice publication-title: Behav. Brain. Res. doi: 10.1016/j.bbr.2018.02.009 – volume: 27 start-page: 101 year: 2017 ident: ref_1 article-title: The neurobiology of depression: An integrated view publication-title: Asian J. Psychiatr. doi: 10.1016/j.ajp.2017.01.025 – ident: ref_90 doi: 10.3390/ijms22041840 – volume: 484 start-page: 12 year: 2010 ident: ref_46 article-title: Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2010.07.084 – volume: 249 start-page: 136 year: 2019 ident: ref_70 article-title: Zinc inhibited LPS-induced inflammatory responses by upregulating A20 expression in microglia BV2 cells publication-title: J. Affect Disord. doi: 10.1016/j.jad.2019.02.041 – ident: ref_77 doi: 10.1371/journal.pone.0030924 – volume: 5 start-page: 11 year: 2004 ident: ref_53 article-title: Role of neurotrophic factors in the etiology and treatment of mood disorders publication-title: Neuromolecular Med. doi: 10.1385/NMM:5:1:011 – volume: 25 start-page: 2777 year: 2019 ident: ref_69 article-title: Avicularin Relieves Depressive-Like Behaviors Induced by Chronic Unpredictable Mild Stress in Mice publication-title: Med. Sci. Monit. doi: 10.12659/MSM.912401 – volume: 28 start-page: 537 year: 2019 ident: ref_83 article-title: Downregulation of SIRT2 by Chronic Stress Reduces Expression of Synaptic Plasticity-related Genes through the Upregulation of Ehmt2 publication-title: Exp. Neurobiol. doi: 10.5607/en.2019.28.4.537 – volume: 70 start-page: 398 year: 2018 ident: ref_27 article-title: Histone deacetylases (HDACs) as therapeutic target for depressive disorders publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2017.08.001 – volume: 32 start-page: 591 year: 2009 ident: ref_31 article-title: Multiple roles of HDAC inhibition in neurodegenerative conditions publication-title: Trends Neurosci. doi: 10.1016/j.tins.2009.06.002 – volume: 100 start-page: 551 year: 2018 ident: ref_66 article-title: Menin Deficiency Leads to Depressive-like Behaviors in Mice by Modulating Astrocyte-Mediated Neuroinflammation publication-title: Neuron doi: 10.1016/j.neuron.2018.08.031 – volume: 8 start-page: 45907 year: 2017 ident: ref_79 article-title: Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice publication-title: Sci. Rep. doi: 10.1038/srep45907 – volume: 1715 start-page: 47 year: 2019 ident: ref_64 article-title: Sericin alleviates restraint stress induced depressive- and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus publication-title: Brain Res. doi: 10.1016/j.brainres.2019.03.020 – volume: 62 start-page: 479 year: 2009 ident: ref_87 article-title: Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression publication-title: Neuron doi: 10.1016/j.neuron.2009.04.017 – volume: 19 start-page: 340 year: 2019 ident: ref_60 article-title: Oxidative stress, inflammatory reactions and apoptosis mediated the negative effect of chronic stress induced by maternal separation on the reproductive system in male mice publication-title: Reprod. Biol. doi: 10.1016/j.repbio.2019.10.003 – volume: 9 start-page: 114 year: 2016 ident: ref_33 article-title: Aberrant Expression of Histone Deacetylases 4 in Cognitive Disorders: Molecular Mechanisms and a Potential Target publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2016.00114 – volume: 59 start-page: 3769 year: 2012 ident: ref_89 article-title: The tail suspension test publication-title: J. Vis. Exp. – volume: 10 start-page: 16278 year: 2020 ident: ref_78 article-title: Alleviation of depression-like behavior in a cystic fibrosis mouse model by Hdac6 depletion publication-title: Sci. Rep. doi: 10.1038/s41598-020-73298-4 – volume: 29 start-page: 737 year: 2013 ident: ref_12 article-title: Antidepressant-like effects and memory enhancement of a herbal formula in mice exposed to chronic mild stress publication-title: Neurosci. Bull. doi: 10.1007/s12264-013-1378-z – volume: 234 start-page: 559 year: 2017 ident: ref_17 article-title: Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex publication-title: Psychopharmacology doi: 10.1007/s00213-016-4498-0 – volume: 81 start-page: 292 year: 2014 ident: ref_76 article-title: Possible additional antidepressant-like mechanism of sodium butyrate: Targeting the hippocampus publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2014.02.017 – volume: 486 start-page: 671 year: 2017 ident: ref_47 article-title: Chronic stress-induced dendritic reorganization and abundance of synaptosomal PKA-dependent CP-AMPA receptor in the basolateral amygdala in a mouse model of depression publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2017.03.093 – volume: 61 start-page: 159 year: 2003 ident: ref_36 article-title: Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats publication-title: Brain. Res. Bull. doi: 10.1016/S0361-9230(03)00104-7 – volume: 85 start-page: 190 year: 2014 ident: ref_41 article-title: Glutamatergic mechanisms associated with stress-induced amygdala excitability and anxiety-related behavior publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2014.04.015 – volume: 33 start-page: 448 year: 2018 ident: ref_9 article-title: Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia publication-title: Neurotox. Res. doi: 10.1007/s12640-017-9835-5 – volume: 53 start-page: 4874 year: 2016 ident: ref_58 article-title: Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome publication-title: Mol. Neurobiol. doi: 10.1007/s12035-015-9408-7 – volume: 146 start-page: 104310 year: 2019 ident: ref_45 article-title: Serotonergically dependent antidepressant-like activity on behavior and stress axis responsivity of acacetin publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2019.104310 – ident: ref_42 doi: 10.3390/diagnostics11010123 – volume: 64 start-page: 320 year: 2016 ident: ref_75 article-title: The potential use of histone deacetylase inhibitors in the treatment of depression publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry. doi: 10.1016/j.pnpbp.2015.03.010 – volume: 40 start-page: 1260 year: 2017 ident: ref_16 article-title: Ketamine Alleviates Depressive-Like Behaviors via Down-Regulating Inflammatory Cytokines Induced by Chronic Restraint Stress in Mice publication-title: Biol. Pharm. Bull. doi: 10.1248/bpb.b17-00131 – volume: 31 start-page: 78 year: 2018 ident: ref_49 article-title: The role of magnesium and zinc in depression: Similarities and differences publication-title: Magnes. Res. doi: 10.1684/mrh.2018.0442 – volume: 14 start-page: 100286 year: 2021 ident: ref_21 article-title: A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice publication-title: Neurobiol. Stress doi: 10.1016/j.ynstr.2020.100286 – volume: 6 start-page: 35042 year: 2016 ident: ref_13 article-title: Chronic stress prior to pregnancy potentiated long-lasting postpartum depressive-like behavior, regulated by Akt-mTOR signaling in the hippocampus publication-title: Sci. Rep. doi: 10.1038/srep35042 – volume: 11 start-page: 179 year: 2018 ident: ref_25 article-title: The role of neuroinflammation and neurovascular dysfunction in major depressive disorder publication-title: J. Inflamm. Res. doi: 10.2147/JIR.S141033 – volume: 2011 start-page: 893905 year: 2011 ident: ref_44 article-title: Dysthymia and apathy: Diagnosis and treatment publication-title: Depress. Res. Treat. – volume: 35 start-page: 693 year: 2011 ident: ref_35 article-title: The role of zinc in neurodegenerative inflammatory pathways in depression publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2010.02.010 – volume: 42 start-page: 876 year: 2017 ident: ref_84 article-title: Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders publication-title: Neurochem. Res. doi: 10.1007/s11064-016-2110-y – volume: 59 start-page: 46 year: 2007 ident: ref_38 article-title: Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats publication-title: Pharmacol. Rep. – volume: 197 start-page: 100 year: 2016 ident: ref_48 article-title: Zinc and imipramine reverse the depression-like behavior in mice induced by chronic restraint stress publication-title: J. Affect Disord. doi: 10.1016/j.jad.2016.03.017 – volume: 25 start-page: 2036 year: 2015 ident: ref_11 article-title: Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2015.08.016 – ident: ref_5 doi: 10.1177/2470547016687996 – volume: 126 start-page: 1383 year: 2019 ident: ref_43 article-title: Animal models of major depression: Drawbacks and challenges publication-title: J. Neural. Transm. (Vienna) doi: 10.1007/s00702-019-02084-y – volume: 67 start-page: 659 year: 2015 ident: ref_34 article-title: Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2015.01.015 – volume: 232 start-page: 355 year: 2015 ident: ref_91 article-title: Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway publication-title: Psychopharmacology doi: 10.1007/s00213-014-3671-6 – volume: 5 start-page: 8415 year: 2015 ident: ref_82 article-title: SIRT2 is involved in the modulation of depressive behaviors publication-title: Sci. Rep. doi: 10.1038/srep08415 – volume: 7 start-page: e00472 year: 2019 ident: ref_2 article-title: Depressive disorders: Treatment failures and poor prognosis over the last 50 years publication-title: Pharmacol. Res. Perspect. doi: 10.1002/prp2.472 – volume: 35 start-page: 744 year: 2011 ident: ref_24 article-title: In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression publication-title: Prog Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2010.08.026 – volume: 11 start-page: 150 year: 2016 ident: ref_30 article-title: Gestational stress induces depressive-like and anxiety-like phenotypes through epigenetic regulation of BDNF expression in offspring hippocampus publication-title: Epigenetics doi: 10.1080/15592294.2016.1146850 – ident: ref_55 doi: 10.3390/nu12092529 – volume: 31 start-page: 1044 year: 2007 ident: ref_7 article-title: Cytokine imbalance in the pathophysiology of major depressive disorder publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2007.03.004 – volume: 128 start-page: 597 year: 2004 ident: ref_56 article-title: Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment publication-title: Neuroscience doi: 10.1016/j.neuroscience.2004.06.054 – volume: 29 start-page: 11451 year: 2009 ident: ref_74 article-title: Antidepressant actions of histone deacetylase inhibitors publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1758-09.2009 – volume: 3 start-page: 151 year: 2001 ident: ref_14 article-title: The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians publication-title: Prim. Care Companion. J. Clin. Psychiatry – volume: 5 start-page: 33 year: 2013 ident: ref_39 article-title: Zinc homeostasis and neurodegenerative disorders publication-title: Front. Aging. Neurosci. doi: 10.3389/fnagi.2013.00033 – volume: 37 start-page: 65 year: 2017 ident: ref_18 article-title: Sodium Phenylbutyrate and Edaravone Abrogate Chronic Restraint Stress-Induced Behavioral Deficits: Implication of Oxido-Nitrosative, Endoplasmic Reticulum Stress Cascade, and Neuroinflammation publication-title: Cell Mol. Neurobiol. doi: 10.1007/s10571-016-0344-5 – volume: 329 start-page: 6 year: 2017 ident: ref_4 article-title: The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder publication-title: Behav. Brain. Res. doi: 10.1016/j.bbr.2017.04.020 – volume: 144 start-page: 213 year: 2019 ident: ref_26 article-title: Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: Reduction in oxidative stress, neuroinflammation, and apoptosis publication-title: Brain. Res. Bull. doi: 10.1016/j.brainresbull.2018.10.010 – volume: 10 start-page: 248 year: 2017 ident: ref_3 article-title: Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant Response publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2017.00248 – volume: 33 start-page: 79 year: 2000 ident: ref_20 article-title: Restraint-induced hypoactivity in an elevated plus-maze publication-title: Braz. J. Med. Biol. Res. doi: 10.1590/S0100-879X2000000100011 – volume: 11 start-page: 537 year: 2020 ident: ref_32 article-title: Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation publication-title: Front. Pharmacol. doi: 10.3389/fphar.2020.00537 – volume: 188 start-page: 316 year: 2008 ident: ref_50 article-title: Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2007.11.012 – volume: 16 start-page: 242 year: 2016 ident: ref_65 article-title: The Anti-apoptotic Effect of Ghrelin on Restraint Stress-Induced Thymus Atrophy in Mice publication-title: Immune. Netw. doi: 10.4110/in.2016.16.4.242 – volume: 18 start-page: 1475 year: 2013 ident: ref_61 article-title: Severe life stress and oxidative stress in the brain: From animal models to human pathology publication-title: Antioxid. Redox. Signal doi: 10.1089/ars.2012.4720 – volume: 5 start-page: 8171 year: 2015 ident: ref_85 article-title: An HDAC-dependent epigenetic mechanism that enhances the efficacy of the antidepressant drug fluoxetine publication-title: Sci. Rep. doi: 10.1038/srep08171 – volume: 31 start-page: 628 year: 2007 ident: ref_72 article-title: Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2006.12.014 – volume: 320 start-page: 225 year: 2017 ident: ref_29 article-title: Quetiapine treatment reverses depressive-like behavior and reduces DNA methyltransferase activity induced by maternal deprivation publication-title: Behav. Brain. Res. doi: 10.1016/j.bbr.2016.11.044 – volume: 167 start-page: 238 year: 2010 ident: ref_15 article-title: Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.01.062 – ident: ref_19 doi: 10.1371/journal.pone.0179399 – volume: 47 start-page: 1062 year: 2004 ident: ref_57 article-title: Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2004.07.035 – volume: 81 start-page: 372 year: 2018 ident: ref_10 article-title: Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2017.08.024 – volume: 2 start-page: 647 year: 2002 ident: ref_62 article-title: The Bcl2 family: Regulators of the cellular life-or-death switch publication-title: Nat. Rev. Cancer doi: 10.1038/nrc883 – volume: 1864 start-page: 533 year: 2018 ident: ref_81 article-title: CDK5-mediated phosphorylation of Sirt2 contributes to depressive-like behavior induced by social defeat stress publication-title: Biochim. Biophys. Acta. Mol. Basis. Dis. doi: 10.1016/j.bbadis.2017.11.012 – volume: 31 start-page: 105 year: 2013 ident: ref_59 article-title: The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2012.12.008 – volume: 492 start-page: 57 year: 2004 ident: ref_51 article-title: Zinc treatment induces cortical brain-derived neurotrophic factor gene expression publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2004.03.038 – volume: 20 start-page: 16 year: 2016 ident: ref_63 article-title: Effects of voluntary exercise on apoptosis and cortisol after chronic restraint stress in mice publication-title: J. Exerc. Nutrition Biochem. doi: 10.20463/jenb.2016.09.20.3.3 – volume: 216 start-page: 585 year: 2011 ident: ref_23 article-title: Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice publication-title: Behav. Brain. Res. doi: 10.1016/j.bbr.2010.08.044 – volume: 115 start-page: 1621 year: 2008 ident: ref_37 article-title: Antidepressant-like activity of zinc: Further behavioral and molecular evidence publication-title: J. Neural. Transm. (Vienna) doi: 10.1007/s00702-008-0115-7 – volume: 32 start-page: 686 year: 2008 ident: ref_67 article-title: Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2007.11.012 – volume: 45 start-page: 1106 year: 2011 ident: ref_73 article-title: Altered sirtuin deacetylase gene expression in patients with a mood disorder publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2011.01.016
SSID	ssj0021415
Score	2.4052198
Snippet	Chronic stress is the key factor contributing to the development of depressive symptoms. Chronic restraint stress (CRS) is well validated and is one of the...
SourceID	doaj pubmedcentral proquest pubmed crossref
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source
StartPage	22
SubjectTerms	an animal model of depression Animals Antidepressants Antidepressive Agents - pharmacology Anxiety Behavior Behavior, Animal - drug effects Brain chronic restraint stress Cytokines Depression - drug therapy Disease Models, Animal Dose-Response Relationship, Drug Epigenetics fluoxetine Fluoxetine - pharmacology Hindlimb Suspension Histone Deacetylases - metabolism Humans Male Mental depression Mental disorders Mice Mice, Inbred C57BL Oxidative stress Pyroptosis Stress, Psychological - metabolism zinc Zinc - pharmacology
SummonAdditionalLinks	– databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fj5QwEG50z0Rf_H0eepqa-GRCtlCg5cmc5200cS8bPc3pC2nLoMQV9hbWnP-Of6lTKOiquScfeIEhHdJhpl9n-g0hT1IGJpWK-4qbyI9CLfzUFIEPXDMpZJ6orlvD-9fi-FienqYLdzy6cWWVg0_sHHXP9mzrttEJT_Pa2B3zKa77JcaimCfPVme-7SFlc62uocZlsmOJt-SE7CxezRcfRgAWYLTqM5scof70a9-AFppQMMtEGm7Fpo7C_1_rzj_LJ3-LR7Mb__dLbpLrbl1KD3pDukUuQXWbXD0c2sHdIT8OqrZ0dbM4G_6y_AK05z5uaF1QdCwIsiGns-WmPrcHqYGqKqcfy8rQk6GcnZYVnaNvokfnq7pB6bamjp-XvoGma1jR0rfdARZUBmhXrNfLzevc9Rqz43X8JjjGC_Tp0H5HEAB3ybvZ0cnhS981ePBNlPLWl7FJCplEScEsKz0C5JyzIk80S8LUaG53rAuuRKFShbBKp7kwgWSxzgOQxsR8l0wqHGqP0DDi3AiZAMbXCHioJMhEd1nDnBupPcKGqc2MYz-337TMEAVZa8j-sgaPPB1fWfXUHxcJP7f2Mgpa1u7uRr3-lDknkCFc1BKviGkRAcQp05CKIlCAtskVKrk_WEzmXEmT_TIQjzweH-Pk28yOqqDe9DKIu1EXj9zrjXPUxGaOcRUbeURsme2WqttPqvJzRzQuRZTEAb9_sVoPyLXQFvoEoR8G-2TSrjfwkFwx39qyWT9y_-BPYXRH0A priority: 102 providerName: ProQuest
Title	Antidepressant-like Effects of Combined Fluoxetine and Zinc Treatment in Mice Exposed to Chronic Restraint Stress Are Related to Modulation of Histone Deacetylase
URI	https://www.ncbi.nlm.nih.gov/pubmed/35011254 https://www.proquest.com/docview/2618240536 https://www.proquest.com/docview/2618917701 https://pubmed.ncbi.nlm.nih.gov/PMC8746513 https://doaj.org/article/096b896b40b74ee590be97f1ae0213ab
Volume	27
WOSCitedRecordID	wos000751068800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1420-3049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021415 issn: 1420-3049 databaseCode: DOA dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1420-3049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021415 issn: 1420-3049 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1420-3049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021415 issn: 1420-3049 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1420-3049 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021415 issn: 1420-3049 databaseCode: PIMPY dateStart: 19970101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZgIMEL4jeBURmJJ6RoTpzE9uM2WoFEq2oMVHiJbOeiRZRkWlI0_h3-Us5OUq2A4IWHRmpzkS-5s----vIdIS8VA6uk5qHmNgmT2IhQ2TIKgRsmhSwy7bs1fHwnFgu5WqnllVZfriaspwfuH9wBpthG4idhRiQAqWIGlCgjDRiduDZu9cWsZwRTA9SKMC71e5gcQf3B177VLLSxYI5zNN6JQp6s_08Z5q-Fklciz-wuuTOkjPSwV_UeuQb1fXLreOzU9oD8OKy7aihpxQcVrqsvQHta4pY2JcU5j_gXCjpbb5pL944zUF0X9HNVW3o6VprTqqZzXDbo9PK8aVG6a-hAnUtPoPW9JDr63r9bgsoA9XV0vdy8KYY2YG48Tz2CY7zG5Ra675ifw0PyYTY9PX4TDr0XQpso3oUytVkpsyQrmSOMR-xacFYWmWFZrKzh7s_kkmtRaqUR8RhVCBtJlpoiAmltyh-RvRqHekJonHBuhcwAQ18CPNYSZGb8hl7BrTQBYaMtcjsQk7t7WucIUJz58t_MF5BX20vOe1aOvwkfOQNvBR2htv8B3Swf3Cz_l5sFZH90j3yY5W2O6FNiRpTyLCAvtqfR-G7TRdfQbHoZhMSoS0Ae99601cRt6mKCmQRE7PjZjqq7Z-rqzHOAS-Ga2POn_-PenpHbsavUieIwjvbJXnexgefkpv3WVe3FhFwXK-GPckJuHE0Xy5OJn2z4bfl2vvz0E3__MgI
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLamgTReuF8KA4wEL0jRHDuN7QeExrZq09oKQUETL5ntOBBRktKksP0dfgC_kWMn6Sigve2Bh740p_Jp8vlcco7Ph9BTSayRQrFAMRMFEdU8kCYLA8s0EVyksfJsDe-HfDwWR0fy9Rr62Z2FcW2VnU30hjotjXtHvgWRvgDv02fxy9nXwLFGuepqR6HRwOLQnn6HlK16cbALz_cZpYO9yc5-0LIKBCaSrA5E38SZiKM4I24UOmRlKSNZGmsSU2k0c69JM6Z4pqSCWF7LlJtQkL5OQyuMcSwRYPIvgR3nroWMH50leCF4w6ZyypgkW18agltbUU7cpFO64vs8RcC_4to_2zN_83eDa__bnbqOrraRNd5utsINtGaLm2hjpyO0u4V-bBd13nb-Ap6Caf7Z4mZ6c4XLDINp1BBzp3gwXZQn7ii4xapI8Ye8MHjSNeTjvMAjsK5472RWViBdl7idMIzf2MpTbtT4rT-CA8pY7NsNG7lRmbZsaW49P6EF1tgFr2TrU0hj7G307kJu0R20XsBS9xCmEWOGi9gCsiLLqBJWxNrXPVNmhO4h0oEnMe38dvefpgnkcQ5vyV9466Hny5_MmuEl5wm_cohcCrq54_6Lcv4xac1YAgmvFvCJiOaRtX1JtJU8C5UF9DMFSm52mExaY1glZ4DsoSfLy_DwXW1KFbZcNDIy5KBLD91t4L_UxNW-IQ6PeoivbIwVVVevFPknPypd8Cjuh-z--Wo9Rhv7k9EwGR6MDx-gK9S1LYU0oOEmWq_nC_sQXTbf6ryaP_L7HaPji942vwAPvJZn
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqgoAL78dCASPBBSlax87G9gGh0u2Kqu2qgoJWvQTbcSBiSZZNFtq_w8_g1zF2ki0LqLceOOSSTORJMs_MeD6EnkpijRSKBYqZKIio5oE0WRhYpongIo2VR2t4v8fHYzGZyIM19LPbC-PaKjub6A11Whr3j7wPkb4A7zNgcT9r2yIOhqOXs6-BQ5ByldYOTqMRkV178h3St-rFzhC-9TNKR9uHW6-DFmEgMJFkdSAGJs5EHMUZcWPRIUNLGcnSWJOYSqOZ-2WaMcUzJRXE9Vqm3ISCDHQaWmGMQ4wA83-BM8YdbASfnCZ7IXjGporKmCT9Lw3Yra0oJ27qKV3xgx4u4F8x7p-tmr_5vtG1__mtXUdX24gbbzYqcgOt2eImurzVAd3dQj82izpvO4JBzoJp_tniZqpzhcsMg8nUEIuneDRdlMdui7jFqkjxUV4YfNg16uO8wPtgdfH28aysgLoucTt5GL-xlYfiqPFbvzUHmLHYtyE2dPtl2qKoufX85BZYYwjeytYnkN7Y2-jdubyiO2i9gKXuIUwjxgwXsYXIIbKMKmFFrH09NGVG6B4inSAlpp3r7p5pmkB-52Qv-Uv2euj58pZZM9TkLOJXTjqXhG4euT9Rzj8mrXlLIBHWAo6IaB5ZO5BEW8mzUFnQBKaAyY1OPpPWSFbJqXD20JPlZfj4rmalClsuGhoZcuClh-42qrDkxNXEIT6PeoivKMkKq6tXivyTH6EueBQPQnb_bLYeo0ugLcneznj3AbpCXTdTSAMabqD1er6wD9FF863Oq_kjr_oYfThvrfkFa5afGw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antidepressant-like+Effects+of+Combined+Fluoxetine+and+Zinc+Treatment+in+Mice+Exposed+to+Chronic+Restraint+Stress+Are+Related+to+Modulation+of+Histone+Deacetylase&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Misztak%2C+Paulina&rft.au=Sowa-Ku%C4%87ma%2C+Magdalena&rft.au=Pa%C5%84czyszyn-Trzewik%2C+Patrycja&rft.au=Szewczyk%2C+Bernadeta&rft.date=2021-12-21&rft.pub=MDPI&rft.eissn=1420-3049&rft.volume=27&rft.issue=1&rft_id=info:doi/10.3390%2Fmolecules27010022&rft_id=info%3Apmid%2F35011254&rft.externalDocID=PMC8746513
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon